{"version":"1.0","provider_name":"Greater Geneva Bern area","provider_url":"https:\/\/ggba.swiss\/en\/","author_name":"mathieu","author_url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/","title":"EPFL researchers pioneer new approach to personalized medicine - Greater Geneva Bern area","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ZI0yhYBleC\"><a href=\"https:\/\/ggba.swiss\/en\/epfl-researchers-pioneer-new-approach-to-personalized-medicine\/\">EPFL researchers pioneer new approach to personalized medicine<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/ggba.swiss\/en\/epfl-researchers-pioneer-new-approach-to-personalized-medicine\/embed\/#?secret=ZI0yhYBleC\" width=\"600\" height=\"338\" title=\"&#8220;EPFL researchers pioneer new approach to personalized medicine&#8221; &#8212; Greater Geneva Bern area\" data-secret=\"ZI0yhYBleC\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/ggba.swiss\/wp\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Sun-bioscience-3.jpg","thumbnail_width":945,"thumbnail_height":430,"description":"A recent innovation from the EPFL Laboratory of Stem Cell Bioengineering will enable the mass production of standardized organoids for the first time. This scalable technology is expected to facilitate the use of organoids in drug development and diagnostics. Organoids are tiny, three-dimensional tissue cultures derived from stem cells. They are crafted to mimic organ [&hellip;]"}